Primary Sclerosing Cholangitis:
From Pathogenetic Insights to Novel Therapies
This EASL School is dedicated to management of liver disease in pregnancy and will be delivered by world-leaders in the field. Focused on the topics covered in the recently published EASL Clinical Practice Guidelines on the management of liver disease in pregnancy the school will cover both chronic hepatic disorders occurring coincidentally in pregnancy and gestational liver disorders. This school aims to equip delegates with the best available evidence in this field and translate it into their practice to improve maternal and foetal outcomes.
The EASL School of Hepatology, focusing on Primary Sclerosing Cholangitis (PSC), will offer deep insights into the pathogenetic mechanisms of PSC, discuss challenges in clinical management, and explore emerging therapeutic concepts. This event, featuring leading experts and interactive sessions, aims to enhance participants’ understanding of liver pathology in PSC and provide practical clinical knowledge through live demonstrations, breakout sessions, and case discussions.
School Organisers:
- Annika Bergquist
- Nora Cazzagon
- Ansgar W. Lohse
- Christoph Schramm
Please note that the programme is subject to change, and will be updated continuously up to the school event.
Aims
- To enhance knowledge and comprehension of primary sclerosing cholangitis through expert lectures, live demonstrations, and networking with leaders in the field.
- To facilitate discussions on complex cases and difficult decisions related to PSC, fostering a collaborative learning environment.
- To provide an environment for building professional relationships that will support participants in advancing their expertise in PSC management.
Learning objectives
- To understand the epidemiology and burden of PSC.
- To assess health-related quality of life considerations and implications in PSC treatment.
- To explore pathogenetic concepts and the role of the gut-liver axis in PSC.
- To examine current and novel endoscopic techniques in managing PSC.
- To evaluate surveillance strategies for colorectal and biliary cancer in PSC.
Target audience
- Clinicians and hepatology/gastroenterology trainees.
- Clinician scientists interested in PSC.
- Medical professionals seeking advanced understanding of PSC.
Top 3 reasons to attend
- Engage with leading specialists in hepatology, gastroenterology, and endoscopy.
- Gain practical insights through live demonstrations and case discussions.
- Network with peers and experts, enhancing career and research opportunities.